Suono Bio, Inc. announced it raised $12.2 Million in an amended filing from an offering of $15.2 Million

Company

Location

About

Suono Bio is a biotechnology company harnessing its proprietary drug delivery platform to transform the treatment of difficult-to-treat diseases by enabling localized delivery of small molecules, biologics, nucleic acids, and gene therapies without the need for encapsulation. This novel approach can cure and/or treat a variety of diseases with superior effectiveness, ultimately revolutionizing therapeutic delivery all together.